(TRNS) Transcat - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8935291075

TRNS: Services, Instruments, Calibration, Repair, Distribution

Transcat, Inc. operates as a leading provider of calibration and laboratory instrument services across the United States, Canada, and international markets. The company is structured into two primary business segments: Service and Distribution. The Service segment delivers a comprehensive suite of offerings, including calibration, repair, inspection, analytical qualification, and preventative maintenance. Additionally, it provides consulting services and operates proprietary systems like CalTrak, a workflow management tool designed to streamline operations for both its service centers and clients. The segment also offers a secure online portal, Compliance, Control and Cost, which enables customers to manage assets and maintain calibration records digitally. This portal enhances operational efficiency and ensures regulatory compliance for its clients.

The Distribution segment focuses on supplying test, measurement, and control instruments, catering to a wide range of industries. It offers value-added services such as equipment calibration and certification, rentals, used equipment sales, and equipment kitting. The segment employs a multi-channel approach to market its products, including a website, digital and print advertising, outbound sales teams, and an inbound call center. This diversified strategy ensures that Transcat effectively meets the varying needs of its customer base.

Transcat primarily serves highly regulated industries, with a significant focus on the life sciences sector. This includes pharmaceutical, biotechnology, medical device companies, and other FDA-regulated entities. Beyond life sciences, the company also supports aerospace and defense, industrial manufacturing, energy, and utilities. These industries rely on precise processes and equipment calibration, making Transcats services and products essential for maintaining operational integrity and compliance.

Transcat, Inc. has been in operation since its incorporation in 1964 and is headquartered in Rochester, New York. The company is publicly traded under the ticker symbol TRNS on the NASDAQ exchange. For more information, visit their official website at https://www.transcat.com.

Ticker Symbol: TRNS
Exchange: NASDAQ
Type: common stock
Country Origin: United States
GICS Sub Industry: Trading Companies & Distributors

Average Volume 20d: 95816
Last Price: 79.15
SMA 20: 81.37
SMA 50: 77.01
SMA 200: 102.17
ATR: 3.81

Market Cap: 743.08M USD
P/E: 42.23
P/E Forward: 37.31
P/B: 2.66
P/S: 2.71
RoE: 6.53

Based on the provided data, Transcats stock is currently trading slightly below its 20-day moving average, indicating short-term weakness. However, the forward P/E suggests investor confidence in future growth. The companys market cap and P/S ratio reflect its established position in the industry. With a moderate ATR, volatility is manageable, making TRNS a stable pick for investors seeking exposure to the calibration and measurement services sector.

Additional Sources for TRNS Stock

TRNS Stock Overview

Market Cap in USD 743m
Sector Industrials
Industry Specialty Business Services
GiC Sub-Industry Trading Companies & Distributors
IPO / Inception 1990-03-27

TRNS Stock Ratings

Growth Rating 45.8
Fundamental 18.9
Dividend Rating 0.0
Rel. Strength -38
Analysts 3.6/5
Fair Price Momentum 76.63 USD
Fair Price DCF 25.64 USD

TRNS Dividends

No Dividends Paid

TRNS Growth Ratios

Growth Correlation 3m 10.5%
Growth Correlation 12m -85.3%
Growth Correlation 5y 83.6%
CAGR 5y 22.50%
CAGR/Max DD 5y 0.43
Sharpe Ratio 12m -0.21
Alpha -43.33
Beta 1.242
Volatility 40.23%
Current Volume 58.5k
Average Volume 20d 91.2k
What is the price of TRNS stocks?
As of May 09, 2025, the stock is trading at USD 79.35 with a total of 58,507 shares traded.
Over the past week, the price has changed by -0.38%, over one month by +6.98%, over three months by +1.89% and over the past year by -31.13%.
Is Transcat a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Transcat is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 18.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRNS as of May 2025 is 76.63. This means that TRNS is currently overvalued and has a potential downside of -3.43%.
Is TRNS a buy, sell or hold?
Transcat has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold TRNS.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for TRNS stock price target?
According to ValueRays Forecast Model, TRNS Transcat will be worth about 87 in May 2026. The stock is currently trading at 79.35. This means that the stock has a potential upside of +9.69%.
Issuer Forecast Upside
Wallstreet Target Price 100.2 26.2%
Analysts Target Price 100.2 26.2%
ValueRay Target Price 87 9.7%